Fidelity Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Sell |
71,731
-11,952
| -14% | -$161K | ﹤0.01% | 3004 |
|
|
2026
Q1 | $1.16M | Sell |
83,683
-3,059
| -4% | -$42.6K | ﹤0.01% | 2818 |
|
|
2025
Q4 | $1.22M | Sell |
86,742
-3,372
| -4% | -$47.3K | ﹤0.01% | 2774 |
|
|
2025
Q3 | $1.26M | Sell |
90,114
-17,235
| -16% | -$248K | ﹤0.01% | 2711 |
|
|
2025
Q2 | $1.61M | Buy |
107,349
+9,356
| +10% | +$134K | ﹤0.01% | 2563 |
|
|
2025
Q1 | $1.29M | Buy |
97,993
+5,387
| +6% | +$74.3K | ﹤0.01% | 2591 |
|
|
2024
Q4 | $1.46M | Buy |
92,606
+13,991
| +18% | +$210K | ﹤0.01% | 2544 |
|
|
2024
Q3 | $1.25M | Buy |
78,615
+595
| +0.8% | +$9.57K | ﹤0.01% | 2540 |
|
|
2024
Q2 | $1.19M | Sell |
78,020
-20,485
| -21% | -$294K | ﹤0.01% | 2476 |
|
|
2024
Q1 | $1.45M | Sell |
98,505
-805
| -0.8% | -$11.8K | ﹤0.01% | 2412 |
|
|
2023
Q4 | $1.38M | Buy |
99,310
+31,770
| +47% | +$425K | ﹤0.01% | 2380 |
|
|
2023
Q3 | $903K | Sell |
67,540
-1,115
| -2% | -$15.1K | ﹤0.01% | 2478 |
|
|
2023
Q2 | $867K | Sell |
68,655
-11,290
| -14% | -$132K | ﹤0.01% | 2509 |
|
|
2023
Q1 | $910K | Buy |
79,945
+23,475
| +42% | +$253K | ﹤0.01% | 2542 |
|
|
2022
Q4 | $584K | Buy |
56,470
+14,845
| +36% | +$160K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $436K | Sell |
41,625
-2,750
| -6% | -$29.3K | ﹤0.01% | 2817 |
|
|
2022
Q2 | $492K | Buy |
44,375
+12,765
| +40% | +$139K | ﹤0.01% | 2855 |
|
|
2022
Q1 | $352K | Buy |
31,610
+25,670
| +432% | +$291K | ﹤0.01% | 3091 |
|
|
2021
Q4 | $78K | Buy |
5,940
+4,850
| +445% | +$61.1K | ﹤0.01% | 3142 |
|
|
2021
Q3 | $15K | Buy |
1,090
+135
| +14% | +$1.8K | ﹤0.01% | 3519 |
|
|
2021
Q2 | $14K | Buy |
955
+40
| +4% | +$559 | ﹤0.01% | 3475 |
|
|
2021
Q1 | $11K | Sell |
915
-325
| -26% | -$4.17K | ﹤0.01% | 3373 |
|
|
2020
Q4 | $17K | Buy |
1,240
+135
| +12% | +$1.82K | ﹤0.01% | 3214 |
|
|
2020
Q3 | $15K | Buy |
1,105
+600
| +119% | +$7.15K | ﹤0.01% | 3121 |
|
|
2020
Q2 | $5K | Sell |
505
-178,455
| -100% | -$1.82M | ﹤0.01% | 3250 |
|
|
2020
Q1 | $1.44M | Buy |
178,960
+39,985
| +29% | +$333K | ﹤0.01% | 2254 |
|
|
2019
Q4 | $1.13M | Buy |
138,975
+22,965
| +20% | +$181K | ﹤0.01% | 2378 |
|
|
2019
Q3 | $879K | Sell |
116,010
-95,990
| -45% | -$714K | ﹤0.01% | 2443 |
|
|
2019
Q2 | $1.59M | Buy |
212,000
+78,500
| +59% | +$617K | ﹤0.01% | 2374 |
|
|
2019
Q1 | $1.08M | Buy |
+133,500
| New | +$1.01M | ﹤0.01% | 2410 |
|
|
2015
Q4 | – | Sell |
-230,500
| Closed | -$2.95M | – | 2767 |
|
|
2015
Q3 | $2.95M | Hold |
230,500
| – | – | ﹤0.01% | 2323 |
|
|
2015
Q2 | $2.55M | Hold |
230,500
| – | – | ﹤0.01% | 2406 |
|
|
2015
Q1 | $2.63M | Sell |
230,500
-24,500
| -10% | -$260K | ﹤0.01% | 2373 |
|
|
2014
Q4 | $2.57M | Sell |
255,000
-82,500
| -24% | -$869K | ﹤0.01% | 2384 |
|
|
2014
Q3 | $3.55M | Buy |
337,500
+13,000
| +4% | +$122K | ﹤0.01% | 2305 |
|
|
2014
Q2 | $2.8M | Buy |
324,500
+39,500
| +14% | +$332K | ﹤0.01% | 2358 |
|
|
2014
Q1 | $2.5M | Sell |
285,000
-181,150
| -39% | -$1.58M | ﹤0.01% | 2340 |
|
|
2013
Q4 | $3.83M | Sell |
466,150
-129,500
| -22% | -$1.02M | ﹤0.01% | 2232 |
|
|
2013
Q3 | $4.5M | Sell |
595,650
-207,500
| -26% | -$1.51M | ﹤0.01% | 2185 |
|
|
2013
Q2 | $6.08M | Buy |
+803,150
| New | +$5.86M | ﹤0.01% | 2082 |
|
Other funds holding RDY
AIM
Fidelity Investments's RDY Position: Q2 2026 in Review
Fidelity Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 14% in Q2 2026, selling an estimated $161K and leaving 71,731 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3004.
Fidelity Investments first reported a position in RDY in Q2 2013 and has held it in 40 quarters since. The position peaked at $6.08M in Q2 2013. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Fidelity Investments held 71,731 shares of Dr. Reddy's Laboratories worth $1.04M as of Q2 2026.
- Fidelity Investments sold 11,952 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $161K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3004 holding.
- Fidelity Investments first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 40 quarters since.
- Fidelity Investments's Dr. Reddy's Laboratories position peaked at $6.08M in Q2 2013.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.